Indoco Remedies

243.61
+0.94
(0.39%)
Market Cap
2,247.30 Cr
EPS
10.53
PE Ratio
126.00
Dividend Yield
0.08 %
Industry
Healthcare
52 Week High
387.55
52 Week Low
190.00
PB Ratio
2.19
Debt to Equity
0.47
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from4 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+75.00 %
+75.00 %
Sell
Sell+25.00 %
+25.00 %

Company News

View All News
Caret
positive
Indoco Remedies Receives FDA Approval for Allopurinol Tablets21 hours ago
Indoco Remedies has received final approval from the U.S. Food and Drug Administration (USFDA) for Allopurinol Tablets USP 200 mg.
negative
Indoco Remedies: Q4 Loss and Revenue Drop Trigger Share Slump1 day ago
Indoco Remedies reported a Q4 consolidated net loss of ₹40.4 crore, compared to a profit last year. Revenue fell 12.5% to ₹384 crore. The company announced a final dividend of ₹0.20 per share. Following the results, the stock fell 7% to ₹242.40.
negative
Indoco Remedies Reports Q4 Financial Results1 day ago
Indoco Remedies has reported its Q4 financial results. The company experienced an EBITDA loss of 7.8 million rupees, compared to a gain of 488 million rupees in the same quarter last year. Revenue decreased to 3.8 billion rupees from 4.4 billion rupees year-over-year. The company also reported a consolidated net loss of 400 million rupees, in contrast to a profit of 227 million rupees in the previous year's corresponding quarter.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,683.60
#1 4,03,952.00
35.21
#1 49,887.20
12.06
#1 9,648
-18.99
40.74
6,483.00
1,72,103.30
78.53
8,184.00
0.89
1,600
23.05
63.44
1,484.20
1,19,866.20
22.74
26,520.70
14.17
4,155
30.28
47.86
3,174.70
1,07,446.30
55.70
10,785.70
11.59
1,656
10.91
43.82
1,230.10
1,02,646.40
#1 18.15
28,905.40
12.36
5,578
21.14
62.40
2,432.40
1,00,355.60
50.56
10,615.60
19.57
1,942
-10.91
44.37
908.60
91,426.40
19.56
19,831.50
13.82
3,831
-0.19
56.78
1,978.90
90,344.90
27.54
20,141.50
#1 19.94
1,936
#1 112.49
44.10
1,197.10
69,527.80
19.71
29,559.20
17.55
3,169
-10.04
50.83
30,795.00
65,437.20
46.30
6,097.20
10.80
1,201
27.83
54.40
Forecast
Actual
Growth Rate
Revenue Growth
9.35 %
Net Income Growth
-31.83 %
Cash Flow Change
-12.37 %
ROE
-36.80 %
ROCE
-35.79 %
EBITDA Margin (Avg.)
-19.41 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
213
237
249
250
248
287
284
264
267
324
334
297
382
374
349
401
396
405
412
429
417
478
461
462
425
432
404
386
Expenses
206
224
238
224
230
260
255
239
227
268
272
250
300
300
285
329
337
345
337
363
365
410
405
401
384
392
399
391
EBITDA
7
13
11
26
18
27
30
25
40
56
62
47
82
74
65
72
60
60
74
66
52
68
56
61
42
40
6
-5
Operating Profit %
3 %
5 %
4 %
9 %
7 %
9 %
10 %
9 %
15 %
17 %
18 %
15 %
21 %
19 %
18 %
18 %
15 %
15 %
18 %
15 %
12 %
13 %
12 %
9 %
10 %
9 %
1 %
-2 %
Depreciation
17
18
18
20
17
18
18
18
19
19
17
19
22
20
19
18
20
16
17
18
20
21
24
26
28
29
29
29
Interest
7
5
4
5
6
5
7
8
6
6
6
5
4
3
4
3
4
5
7
9
8
8
10
12
14
18
16
18
Profit Before Tax
-12
-10
4
9
-0
10
11
8
24
37
38
34
61
65
51
60
48
67
38
39
34
46
23
33
7
-5
-31
-46
Tax
0
-3
-1
-2
-2
2
2
2
7
11
12
9
22
23
18
19
10
18
10
13
10
11
7
11
5
5
-3
-4
Net Profit
-12
-7
5
12
2
8
9
5
17
26
25
25
40
42
33
41
39
50
28
26
24
35
16
22
2
-10
-28
-41
EPS in ₹
-1.32
-0.81
0.57
1.25
0.20
0.85
0.99
0.58
1.85
2.78
2.75
2.71
4.30
4.52
3.58
4.39
4.19
5.40
3.05
2.80
2.62
3.82
1.69
2.39
0.20
-1.09
-3.08
-4.48

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
846
941
1,197
1,238
1,258
1,272
1,315
1,486
1,658
2,145
Fixed Assets
340
374
440
489
468
590
570
555
678
954
Current Assets
385
465
572
539
538
563
623
774
814
955
Capital Work in Progress
63
55
91
136
185
51
68
122
114
125
Investments
0
16
0
0
0
0
0
0
3
9
Other Assets
443
496
666
614
605
631
677
809
864
1,057
Total Liabilities
846
941
1,197
1,238
1,258
1,272
1,315
1,486
1,658
2,145
Current Liabilities
262
303
390
417
446
459
407
425
425
612
Non Current Liabilities
65
61
155
146
152
133
139
157
205
422
Total Equity
519
577
651
675
661
680
769
905
1,028
1,111
Reserve & Surplus
500
558
633
657
642
661
751
886
1,010
1,092
Share Capital
18
18
18
18
18
18
18
18
18
18

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-0
50
-52
12
3
-14
8
-7
4
Investing Activities
-88
-111
-171
-135
-104
-56
-67
-121
-208
-433
Operating Activities
109
112
89
123
132
123
82
174
179
157
Financing Activities
-20
-2
132
-39
-16
-64
-30
-44
23
280

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.74 %
58.74 %
58.72 %
58.75 %
58.75 %
58.80 %
58.90 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.12 %
0.12 %
1.59 %
1.69 %
1.91 %
1.47 %
1.70 %
1.25 %
1.24 %
DIIs
18.88 %
18.80 %
17.22 %
17.23 %
17.64 %
17.52 %
17.33 %
18.07 %
17.29 %
17.78 %
19.56 %
19.41 %
18.67 %
18.24 %
18.90 %
18.75 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
15.92 %
15.92 %
17.32 %
17.87 %
17.87 %
17.23 %
16.85 %
16.74 %
16.48 %
16.84 %
15.24 %
15.33 %
16.29 %
16.30 %
16.07 %
15.99 %
Others
6.52 %
6.59 %
6.78 %
6.21 %
5.80 %
6.57 %
7.13 %
6.39 %
7.42 %
5.04 %
4.77 %
4.62 %
4.81 %
5.01 %
4.99 %
5.12 %
No of Share Holders
21,508
24,518
34,746
37,279
37,863
38,498
38,072
35,713
34,731
36,588
32,600
33,201
34,511
34,416
34,676
34,497

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1.6 1 0.3 0.3 1.5 2.25 2.25 1.5 0.00
Dividend Yield (%) 0.00 0.75 0.49 0.14 0.1 0.4 0.69 0.68 0.64 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
22 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 May 2025 251.12 261.58
21 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 Jan 2025 326.65 335.15
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 336.65 319.95
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 365.50 365.50
19 Sept 2024 DIVIDEND Dividend
₹ 1.50 /share
19 Sept 2024 327.55 369.65
19 Sept 2023 DIVIDEND Dividend
₹ 2.25 /share
18 Sept 2023 347.80 356.80
16 Sept 2022 DIVIDEND Dividend
₹ 0.75 /share
14 Sept 2022 331.60 359.35
15 Sept 2022 DIVIDEND Dividend
₹ 1.50 /share
14 Sept 2022 331.60 365.20
21 Sept 2021 DIVIDEND Dividend
₹ 1.50 /share
17 Sept 2021 358.65 473.05

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication18 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation20 hours ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release21 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
Appointment Of Secretarial Auditor And Internal Auditor Of The Company1 day ago
Announcement under Regulation 30 (LODR)-Change in Directorate1 day ago
Financial Results For The Year Ended 31St March 20251 day ago
Board Meeting Outcome for Financial Results For The Year Ended 31St March 2025 And Recommendation Of A Final Dividend1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
Board Meeting Intimation for Audited Results & Dividend9 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 28, 2025
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations2015 (Listing Regulations)Mar 27, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Mar 25, 2025
Intimation Of Appointment Of Cost Auditor Of The Company Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 21, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 12, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 10, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 10, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2025
REVISED DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS2015 (LISTING REGULATIONS) Feb 28, 2025
DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS2015 (LISTING REGULATIONS)Feb 25, 2025
DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS2015 (LISTING REGULATIONS)Feb 25, 2025
SHOW CAUSENOTICE - ORDER OF DROPPED PROCEEDINGFeb 25, 2025
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 14, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 14, 2025
SHOW CAUSE NOTICEFeb 12, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 11, 2025
SHOW CAUSE NOTICEFeb 11, 2025
SHOW CAUSE NOTICE - ORDER OF DROPPED PROCEEDINGFeb 06, 2025
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 03, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJan 31, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 24, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 21, 2025
Integrated Filing (Financial)Jan 21, 2025
Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2024Jan 21, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 21St January 2025Jan 21, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 15, 2025
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31-12-2024Jan 13, 2025
Change Of Name Of Registrar & Share Transfer Agent (RTA) Of The CompanyJan 07, 2025

Technical Indicators

RSI(14)
Neutral
47.81
ATR(14)
Volatile
10.74
STOCH(9,6)
Neutral
65.67
STOCH RSI(14)
Neutral
66.67
MACD(12,26)
Bullish
0.85
ADX(14)
Weak Trend
22.48
UO(9)
Bearish
32.70
ROC(12)
Uptrend And Accelerating
1.43
WillR(14)
Neutral
-61.61